![Marlies Janßen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marlies Janßen
Direttore/Membro del Consiglio presso
NSI N.V.
Profilo
Marlies Janßen is currently the Co-Managing Director at Fortuna Herstellung GmbH.
She also holds positions as a Member-Supervisory Board at NSI NV and Erasmus Q-Intelligence BV.
Previously, Ms. Janßen served as the Managing Director at cas central compounding Baden-Württemberg GmbH.
Posizioni attive di Marlies Janßen
| Società | Posizione | Inizio |
|---|---|---|
| NSI N.V. | Direttore/Membro del Consiglio | 28/02/2024 |
Fortuna Herstellung GmbH
 Fortuna Herstellung GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Amministratore Delegato | - |
Erasmus Q-Intelligence BV | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Marlies Janßen
| Società | Posizione | Fine |
|---|---|---|
cas central compounding Baden-Württemberg GmbH
 cas central compounding Baden-Württemberg GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparation services | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
11
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
NSI NV
 NSI NV Real Estate Investment TrustsFinance Operates as a commercial real estate investment company with a focus on office buildings | Finance |
Fortuna Herstellung GmbH
Fortuna Herstellung GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
cas central compounding Baden-Württemberg GmbH
cas central compounding Baden-Württemberg GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical preparation services | Health Technology |
Erasmus Q-Intelligence BV |
